318 related articles for article (PubMed ID: 23042199)
1. Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway.
Meng J; Zou Y; Hu C; Zhu Y; Peng Z; Hu G; Wang Z; Tao L
Shock; 2012 Nov; 38(5):567-73. PubMed ID: 23042199
[TBL] [Abstract][Full Text] [Related]
2. Fluorofenidone attenuates TGF-β1-induced lung fibroblast activation via restoring the expression of caveolin-1.
Liu J; Song C; Xiao Q; Hu G; Tao L; Meng J
Shock; 2015 Feb; 43(2):201-7. PubMed ID: 25394239
[TBL] [Abstract][Full Text] [Related]
3. FLUOROFENIDONE ATTENUATES PULMONARY INFLAMMATION AND FIBROSIS BY INHIBITING THE IL-11/MEK/ERK SIGNALING PATHWAY.
Song C; Liu X; Tan W; Guo X; Mao Y; Zhou Q; Geng S; Hu Y
Shock; 2022 Aug; 58(2):137-146. PubMed ID: 36166195
[TBL] [Abstract][Full Text] [Related]
4. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.
Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J
J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439
[TBL] [Abstract][Full Text] [Related]
5. Nintedanib modulates surfactant protein-D expression in A549 human lung epithelial cells via the c-Jun N-terminal kinase-activator protein-1 pathway.
Kamio K; Usuki J; Azuma A; Matsuda K; Ishii T; Inomata M; Hayashi H; Kokuho N; Fujita K; Saito Y; Miya T; Gemma A
Pulm Pharmacol Ther; 2015 Jun; 32():29-36. PubMed ID: 25843005
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G
Respiration; 2012; 84(6):509-17. PubMed ID: 23006535
[TBL] [Abstract][Full Text] [Related]
8. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
9. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
10. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
11. 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis.
Gurrieri C; Piazza F; Gnoato M; Montini B; Biasutto L; Gattazzo C; Brunetta E; Cabrelle A; Cinetto F; Niero R; Facco M; Garbisa S; Calabrese F; Semenzato G; Agostini C
J Pharmacol Exp Ther; 2010 Mar; 332(3):785-94. PubMed ID: 19959748
[TBL] [Abstract][Full Text] [Related]
12. Fluorofenidone attenuates bleomycin-induced pulmonary fibrosis by inhibiting eukaryotic translation initiation factor 3a (eIF3a) in rats.
Wu YH; Li XW; Li WQ; Li XH; Li YJ; Hu GY; Liu ZQ; Li D
Eur J Pharmacol; 2016 Feb; 773():42-50. PubMed ID: 26821114
[TBL] [Abstract][Full Text] [Related]
13. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
15. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis.
Higashiyama H; Yoshimoto D; Kaise T; Matsubara S; Fujiwara M; Kikkawa H; Asano S; Kinoshita M
Exp Mol Pathol; 2007 Aug; 83(1):39-46. PubMed ID: 17274978
[TBL] [Abstract][Full Text] [Related]
17. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
[TBL] [Abstract][Full Text] [Related]
18. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
19. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis.
Wang XM; Zhang Y; Kim HP; Zhou Z; Feghali-Bostwick CA; Liu F; Ifedigbo E; Xu X; Oury TD; Kaminski N; Choi AM
J Exp Med; 2006 Dec; 203(13):2895-906. PubMed ID: 17178917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]